The concentration of urogastrone (URO) and lactose was measured in breast secretions from four women. URO levels were high in precolostrum and fell markedly around the time of parturition to relatively constant low levels in mature milk. When milk samples were fractionated on a Biogel PI0 column, the major peak of immunoreactivity occurred at the point at which pure URO eluted.
Human milk is a food source specifically tailored to the needs of the newborn infant and fulfis all the child's nutritional requirements for the first 4-6 months of life and up to three-quarters of his needs from 6-12 months of age (33) . For a great many years cow's milk has substituted for human milk in feeding the newborn infant. With this use came an interest in comparing the composition of the two milks in an attempt to justify the continued use of this substitution (for reviews see 15 and 32) ; however, it is now commonly accepted that human milk is of greater nutritional value in feeding the newborn infant than cow's milk (1, 21) . Furthermore, milk does not just f u l f i a nutritional role, but contains antibody molecules and other antimicrobial factors that are involved in the transfer of passive immunity (27, 28) , and hormones and growth factors of unknown function (3, 23, 31) . The concentration of hormones and growth factors in milk varies between species, presumably reflecting the varying needs of the neonate. Although we do not understand the role these molecules play in the neonate, it becomes important to compare their levels throughout lactation.
In the study to be reported here we monitored the concentration of URO (the human equivalent of mouse EGF) in precolostrum, colostrum, and mature milk, from human donors.
MATERIALS AND METHODS
Milk samples. Milk was obtained from five individuals at various stages of pregnancy and lactation. Samples from four of the volunteers (CK, AR, JL, and KD) were supplied during antenatal and postnatal periods and were assayed after up to 12 months in storage at -40°C. The 5th donor (CL) only provided mature milk samples, and these were assayed within 4-8 wk of collection.
Milk was manually expressed into the sterile universal containers provided, and stored in a domestic freezer compartment until they were transferred to storage at -40°C in the laboratory.
Samples were centrifuged at 9000 x g in a Microfuge (Beckman RIIC Ltd.) and the aqueous phase withdrawn from below the floating lipid layer and assayed for URO activity.
For the purposes of this study, we considered all milk produced before delivery as being precolostrum, milk produced during the first 48 h after delivery as colostrum, and milk produced after the first 48 h postpartum as mature milk. Donors CK, AR, and JL who were hypersecretory produced greater volumes of precolostrum than KD who had to collect small samples of precolostrum over many expressions to give weekly samples.
URO radioimmunoassay. An homologous, highly sensitive radioimmunoassay (RIA) for URO has previously been described in detail (13) and was employed for this study. Pure URO and its antiserum were kindly supplied by Dr. H. Gregory (I.C.I. Pharmaceuticals, Alderley Edge, U.K.).
Iodination of URO was by a modification of the chloramine T method of Hunter and Greenwood (20) . One microgram amounts were iodinated and free iodine was separated from labelled URO by fractionation on a Biogel P6 column. The iodinated URO had a mean specific activity of 184 yCi/pg and was stored at -20°C for up to 3 wk. The label was diluted immediately before use and approximately 15 pg of starting peptide was incubated per assay tube.
Antibody bound and free label was separated by the addition of goat anti-rabbit serum and milk samples were assayed at dilutions of 1:20 to 1:200 depending on their URO content. When milk at these dilutions was incubated with the label and a large excess of antibody, there was no change in total binding compared to that when milk was absent. Standardised samples of urine (54 &litre) were included in each assay, and in effect provided a second standard curve.
Lactose assay. Defatted milk samples were assayed for lactose content by the method of Kottler, Tierney, and Rosensweig (24) . The majority of milk samples were assayed in a minimum of three assays (subject to sample size), and at dilutions of 1:40 or 1:80 in 0.1 M potassium phosphate buffer, pH 7.2.
RESULTS

Radioimmunoassay characteristics.
The RIA for URO used in this study was sensitive to 50 pg per sample and inter-(27%) and intraassay (6%) variations were calculated according to Rodbard (29) , on a series of diluted milk samples. Dilution dose response curves for human milk (dilutions of 1:20 to 1:100) and urine were parallel to that of the pure URO standards (Fig. 1) .
Milk URO concentrations. A comparison of URO concentrations in mature milk after long term (12 months) and short term (4-8 wk) storage showed no significant difference suggesting that long term storage of samples had no effect on the measurement of URO by RIA.
For three of the individuals (CK, AR, JL) whose milk samples were studied in detail, URO concentrations were high in preco- Fig. 2 ). Colostrum concentrations of URO varied extensively (35-438 ng/ml) depending on the time, pre-or postpartum, when colostrum levels started to fall down to those found in mature milk (Fig. 2) .
When pooled precolostrum or mature milk samples were fractionated on a Biogel PI0 column, the major peak of immunoreactivity occurred at the point at which pure standard URO eluted (Fig. 3) . This accounted for the majority of the assayable URO in parallel unfractionated samples. A small peak of immunoreactivity occurred in the void volume, but this only represented very low levels of material. Indeed, the fractions under this peak appeared cloudy, indicating the presence of high concentrations of large milk proteins, and this may be giving rise to non-specific interference in the RIA.
Milk lactose concentrations. The standard curve for lactose was linear between 12.5 and 500 nmole per sample, and for a series of diluted milk samples, the intraassay variation was calculated to be 2.4% and the interassay variation 25%. The lactose levels in the milk from donor AR increased through birth and showed good correlation with the reduction in URO concentration at this time (Fig. 2) . Although the URO concentrations measured in samples from donor JL decreased prepartum this again was accompanied by a corresponding increase in lactose levels; however, in this individual lactose levels decreased again before continuing to rise postpartum (Fig. 2) .
In contrast to the other donors, URO concentrations in samples from donor CK were extremely variable and decreased through birth down to low levels in mature milk. This fall in URO tors and this was in direct contrast to the already reported high levels of antimicrobial factors in precolostrum from this donor (28) . The pattern of URO levels in breast secretions i.e., high in precolostrum, falling during colostrum formation, with a steady -EGF resulted in a significant uptake of this peptide by the mammary gland of the goat and transport into milk (4). EGF/URO would seem to be ideally suited to play a role in the gut as it is not affected by low pH and survives limited proteolytic digestion (12) . The mitogenic action of EGF/URO Fraction number
both in vivo and in vitro has been well documented (7) and indeed Fig. 3 . Biogel P10 chromatography (column size 1.7 x 25 cm) of pooled precolostrum (175 pl) and mature milk (700 pl) from donor CK, applied as a diluted 2.5 ml sample in eluent buffer at 4OC.
concentration partially correlated with the postpartum rise in lactose levels (Fig. 2) . The normal secretor (KD) had milk URO levels which fell slowly throughout the prepartum period and during birth. This showed an inverse correlation with the slow rise in lactose levels throughout the prepartum period (Fig. 2) .
DISCUSSION
URO in human milk has been shown to be biologically active when assayed on fibroblasts in tissue culture (6) . The concentrations of this peptide measured in precolostrum in this study were very high and represent the most concentrated source of URO so far detected (14, 19, 31) . Invariably, there was a reduction in URO concentration either before or during the colostral phase and this correlated with the reported reduction in levels of antimicrobial factors in the same milk samples (28) . This reduction resulted in donors CK and AR supplying their neonates with a concentrated package of URO in colostrum during the first 48 h postpartum; however, colostrum levels reported for donors JL and KD were much lower and similar to those for mature milk. Concentrations of URO measured in mature milk were relatively low and compared favourably with the already reported level of 80 ng/ml(3 1); however, the increased volume of milk supplied to the neonate during established lactation would result in the gastrointestinal tract being exposed to a relatively large amount of URO.
The reduction in levels of other milk components just after birth has been shown to be due to the rise in milk lactose concentrations during this period (16) ; however, as some of our donors showed a decrease in URO concentration before birth we thought it necessary to measure lactose levels at this time in an attempt to explain the prepartum drop in URO concentration. Lactose levels in precolostrum, colostrum, and mature milk were similar to those already reported (16, 25) . In two of the women (AR and JL) the decrease in URO concentration was matched or preceeded by an increase in the lactose concentration in the samples. This was also true for (CK) if one considered the drop in URO levels just before birth to be part of the overall variability in URO concentrations observed in precolostrum samples from this individual. The gradual decrease in URO concentration in the prepartum period in the normal secretor (KD) was matched by a gradual increase in milk lactose concentration; however, the URO levels in precolostrum reported for this individual were in general lower than those measured in the other three hypersecrean increase in DNA content of the small intestine' was reported (17, 34) , when neonates were fed colostrum as an alternative to water or an isocaloric artificial formula. Furthermore, there is a large amount of evidence to show that EGF/URO exerts atrophic effect on the mucosa of the stomach and small intestine of both adult and neonatal animals (2, 5, 9, 10, 22, 26, 30) . Although URO has also been localized in Brunner's gland in the adult human duodenum (18) , its presence in the newborn has not been investigated.
Gregory (1 1) first identified URO by its ability to inhibit gastric acid secretion after intravenous administration; however, recent evidence in adult rats suggests that when EGF/URO is given intragastrically it is unable to alter gastric acid secretion (8) . The URO in milk may therefore have no role to play in lowering the pH of the stomach contents but could still exert a growth-promoting effect on the gastrointestinal tract of the neonate.
